Question 1

What is the catalog number for 2- (4-Nitrophenyl) thiophene?

Accepted Answer

The catalog number for 2- (4-Nitrophenyl) thiophene is FN151243.

Question 2

What sizes are available for 2- (4-Nitrophenyl) thiophene?

Accepted Answer

2- (4-Nitrophenyl) thiophene is available in the following size(s): 100 mg, 250 mg, 500 mg, 1000 mg.

Question 3

How many pack sizes does 2- (4-Nitrophenyl) thiophene come in?

Accepted Answer

2- (4-Nitrophenyl) thiophene is available in 4 different pack sizes.

Question 4

Is 2- (4-Nitrophenyl) thiophene in stock?

Accepted Answer

2- (4-Nitrophenyl) thiophene is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 6

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 7

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

2- (4-Nitrophenyl) thiophene

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

2-(5-Bromo-2-fluorophenyl)ethanamine

SOX17 Human Gene Knockout Kit (CRISPR)

Rat FAS/CD95 (Factor Related Apoptosis) ELISA Kit

Rat FAS/CD95 (Factor Related Apoptosis) ELISA Kit

Rat FAS/CD95 (Factor Related Apoptosis) ELISA Kit

Elab Fluor® 488 Anti-Human CD37 Antibody[IPO-24]